2024. Harnessing Immune Checkpoint Inhibitors Against Gastric Cancer: Charting the Course to Expanded Therapeutic Benefit. Biomedical Research and Therapy. 11, 4 (Apr. 2024), 6305–6325. DOI:https://doi.org/10.15419/bmrat.v11i4.877.